CLEARNOTE HEALTH—LAUNCH OF AVANTECT TEST
Branding and launching a breakthrough in early pancreatic cancer detection
MY ROLE
POSITIONING, MESSAGE DEVELOPMENT, CREATIVE DIRECTION
FROM
Pancreatic cancer is one of the deadliest cancers — often diagnosed too late for effective intervention. A groundbreaking cfDNA blood test had the potential to shift that trajectory, but pre-commercial, the test was without a brand name, brand identity, or platform to tell its story. The company behind it needed visibility, urgency, and trust.
TO
A bold new name, a distinct brand, and a confident debut. Supporting a new company name ClearNote Health, and the development of the Avantect brand and test name, a full website was launched within three months — just in time for the JP Morgan Healthcare Conference. The launch was supported with continued educational content and digital marketing, helping establish ClearNote Health as a forward-looking leader in early cancer detection.
